Innovation Compounding
UEI: STA4EJ2MX591
• CAGE: 7RDF0
Overview
Awardee Type
Parent
Federal Capability Statement
Innovation Compounding is a compounding pharmacy that supports over 6000 prescribers, 65,000 patients and annually provides 60,000 prescriptions across the nation. We commit to individualized pharmaceutical care through being Relentless in our drive for personalized medicine, Compassionate toward our patients and doctors, as well as being a Wellness Advocate for our patients' lives and state of well being.
It is our passion to enhance our patient's quality of life!
Keywords
Sterile compounding, non-sterile compounding
Headquarters
Kennesaw, GA
United States
United States
Federal recipient
INNOVATION COMPOUNDING, INC.
(UEI STA4EJ2MX591, CAGE 7RDF0)
is headquartered in Kennesaw GA.
Its primary registered NAICS is 446110 Pharmacies And Drug Stores.
The corporation
was founded in January 2007 and
federally registered in
November 2016.
Federal Registration and Certifications
Legal Name
INNOVATION COMPOUNDING, INC.
UEI
STA4EJ2MX591
CAGE Code
7RDF0
Primary NAICS
SBA Certifications
None
Self Certifications
Self-Certified Small Disadvantaged Business
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
Jan. 1, 2007
Initial Registration
Nov. 9, 2016
Last Registration
Jan. 7, 2022
Registration Activation
Jan. 11, 2021
Registration Expiration
Jan. 7, 2022
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
GA
Country of Incorporation
USA
Employees
<500
Reported NAICS
Accepts Credit Cards
Yes